Our portfolio
includes complex
generics such as
injectables, inhalers,
and extended-
release formulations
that require specialized
development and
commercialization
pathways. With
decades of
experience
navigating LATAM’S
regulatory and market
environments, we
enable efficient
approvals,
sustainable supply,